Small Business: Non-HIV Anti-Infective Therapeutics Special Emphasis Panel [IDM-Q 10]

[ZRG1 IDM-Q 10 Meeting Rosters]

The Non-HIV Anti-Infective Therapeutics Special Emphasis Panel [ZRG1 IDM-Q 10] reviews Small Business Innovation Research [SBIR] and Small Business Technology Transfer Research [STTR] grant applications that focus on the development of therapeutic agents to combat bacterial, viral, fungal, parasitic, prion infections and disease vectors. Specific areas covered by ZRG1 IDM-Q 10

  • Development and/or testing of novel anti-infective agents or of therapeutic process to fight infective agents using culture systems or animal models.
  • Development of traps, biocides or pesticides active against infectious disease vectors.
  • Development of processes to optimize industrial production of non-HIV anti-infective agents.

Study sections with most closely related areas of similar science listed in rank order are:


Small Business: Non-HISV Infectious Agent Detection/Diagnostics, Food Safety, Sterilization/Disinfection and Bioremediation Special Emphasis Panel (IDM IRG) 
Drug Discovery and Development (BCMB IRG) 
Delivery Systems and Nanotechnology (BST IRG) 
Immunology Small Business Activities Special Emphasis Panel (IMM IRG) 
AIDS Biological Sciences (AARR IRG)  



Home | Contact CSR | Staff Directory | Site Map | FOIA | Disclaimer & Privacy Statements | Accessibility Statement
Last updated: December 05, 2008

National Institutes of Health National Institutes of Health   Department of Health and Human Services Department of Health and Human Services USA.gov Government Made Easy